SF-36 physical function scores increased more with tirzepatide than with placebo, an indication that participants perspective on their physical functioning was more likely to improve with tirzepatide
A parallel programme, REIMAGINE, is evaluating CagriSema specifically in type 2 diabetes
2025 was a challenging year for the UK biotech sector, but it ended the year with signs of "renewed confidence," says the BIA industry body
This medication was shown to reduce the risk of CKD progression and renal failure, as well as dialysis initiation, in the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease trial, which involved participants with type 2 diabetes who had albuminuria and advanced CKD
The provider documents class 3 obesity, BMI 41.2, and starts a GLP-1 medication
Li et al used tetrahedral framework nucleic acid (tFNA) to synthesize tFNA-Cur, a nanoparticle that can deliver the natural compound curcumin to the bone marrow, thereby enhancing the bioavailability and stability of curcumin